isopentenyladenosine has been researched along with Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, M; Honma, Y; Ishii, Y; Ishikura, H; Kiyota, H; Tsumura, H | 1 |
Agris, PF; Burns, DM; Rodi, CP | 1 |
Chheda, GB; Evans, JT; Mittelman, A | 1 |
3 other study(ies) available for isopentenyladenosine and Leukemia
Article | Year |
---|---|
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Topics: Acetates; Cell Differentiation; Cyclopentanes; Cytokinins; Esters; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; Isopentenyladenosine; Leukemia; Oxylipins; Tumor Cells, Cultured | 2009 |
Natural occurrence of an inhibitor of mammalian cell growth in human and mouse cells of normal and tumor origin.
Topics: Adenosine; Animals; Cell Line; Cytoplasm; DNA, Neoplasm; Humans; Isopentenyladenosine; Leukemia; Mice; Neoplasm Proteins; RNA, Neoplasm; RNA, Transfer | 1976 |
Cytokinins as chemotherapeutic agents.
Topics: Adenosine; Cytokinins; Drug Evaluation; Humans; Isopentenyladenosine; Leukemia; Multiple Myeloma; Plant Growth Regulators | 1975 |